IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in developing, testing, and commercializing therapies using extensive real-world data, predictive analytics, and technology platforms. Its Technology and Analytics Solutions segment delivers healthcare data, decision-support tools, and software to clients such as manufacturers, providers, payers, and policymakers, helping them optimize clinical and commercial performance. The Research and Development Solutions segment focuses on outsourced clinical trial services, including late-stage and virtual clinical trials for drugs, devices, and diagnostics. IQVIA also offers contract sales and medical solutions that assist with commercialization and field-based engagement. Founded in 1950 and headquartered in Durham, North Carolina, IQVIA plays a central role in the healthcare ecosystem by enabling more efficient evidence generation, regulatory submissions, and market access strategies across more than 100 countries worldwide.
Website2400 Ellis Road
Durham, NC, 27703
United States
IQVIA's (IQV) Commercial Solutions segment is expected to see a "meaningful" tailwind from 20 novel
IQVIA Holdings (IQV) has an average rating of overweight and mean price target of $286.65, according
Investors talking about IQV also mention
| # | Name | Attention |
|---|---|---|
| 1 | Veeva Systems Inc.VEEV | 0%0 |
| 2 | ICON plcICLR | 0%0 |
| 3 | Medpace Holdings, Inc.MEDP | 0%+0 |
| 4 | CTLT - Catalent, Inc. | —— |
| 5 | Neurocrine Biosciences, Inc.NBIX | 0%new |
| 6 | Veralto CorporationVLTO | 0%new |
| 7 | Thermo Fisher Scientific Inc.TMO | 0%0 |
| 8 | Revvity Inc.RVTY | 0%0 |
| 9 | Labcorp Holdings Inc.LH | 0%0 |
| 10 | Xylem Inc.XYL | 0%-0.01 |
What share of all stock conversation is about IQV?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% +0 | 0% 0 |
Of the messages about IQV that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 100% | 99.34% +24.34 | 60.44% -14.11 | ||
| Bearish | — | 0% | 0.66% -24.34 | 39.56% +14.11 |
Of the messages about IQV that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 83.33% | 89.8% | 10.43% | 39.06% | ||
| Technical Analysis | 8.33% | 6.12% | 3.75% | 6.7% | ||
| Earnings | 0% | 2.04% | 27.55% | 24.41% | ||
| Analysts | 8.33% | 2.04% | 30.83% | 15.19% | ||
| Macro | 0% | 0% | 27.43% | 14.65% | ||
| Controversies | 0% | 0% | 0% | 0% |
Of the messages about IQV, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 90.91% | 19.06% | 14.47% | 19.09% | ||
| Newcomers | 9.09% | 80.94% | 85.53% | 80.91% |